Janssen Pharmaceutica Products L P

Actinium Pharmaceuticals, based in New York City, specializes in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapies aimed at improving outcomes for patients who have not responded to existing oncology treatments. With advanced candidates like Actimab-A for acute myeloid leukemia (AML) and Iomab-ACT for cell and gene therapies, Actinium is committed to enhancing patient access and therapeutic efficacy. The company holds 230 patents related to its technologies, including innovations in the manufacture of Ac-225 isotopes. Actinium's research and development initiatives also include several preclinical programs focused on solid tumor indications, highlighting its robust pipeline and commitment to oncology advancements. Generated from the website

Boehringer Ingelheim Pharmaceuticals Inc, based in Plano, TX, is a leading pharmaceutical company focused on research, development, and manufacturing of innovative medicines. The company is dedicated to improving human and animal health through cutting-edge pharmaceutical solutions. With a commitment to scientific excellence and a global presence, Boehringer Ingelheim Pharmaceuticals Inc strives to address unmet medical needs and provide high-quality healthcare products to patients worldwide. The company's diverse portfolio includes a range of therapeutic areas, from respiratory and cardiovascular diseases to oncology and immunology. Generated from their business information

Pharmaceutical Strategies Group, based in Plano, TX, is a company that specializes in providing strategic solutions for pharmaceutical organizations. With a focus on optimizing operations and enhancing market performance, Pharmaceutical Strategies Group offers tailored consulting services to support the unique needs of its clients in the healthcare industry. Generated from their business information